Now showing items 1-20 of 20

    Issue DateTitleAuthor(s)
    1 November 2018Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT  Kessler, D; Burns, A; Tallon, D; et al.
    19 July 2022A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study  Gamble, LD; Parker, S; Quinn, C; et al.
    29 June 2017Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.  Webster, L; Groskreutz, D; Grinbergs-Saull, A; et al.
    30 July 2020Dementia prevention, intervention, and care: 2020 report of the Lancet Commission  Livingston, G; Huntley, J; Sommerlad, A; et al.
    1 May 2017Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.  Webster, L; Groskreutz, D; Grinbergs-Saull, A; et al.
    1 March 2019Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT  Clare, L; Kudlicka, A; Oyebode, JR; et al.
    15 March 2019Goal-oriented cognitive rehabilitation in early-stage Alzheimer's disease: a multi-centre single-blind randomised controlled trial (GREAT)  Clare, L; Kudlicka, A; Oyebode, JR; et al.
    29 June 2022How do electronic risk assessment tools affect the communication and understanding of diagnostic uncertainty in the primary care consultation? A systematic review and thematic synthesis.  Burns, A; Donnelly, B; Feyi-Waboso, J; et al.
    12 November 2021Impact of COVID-19 on ‘living well’ with mild-to-moderate dementia in the community: findings from the IDEAL cohort  Clare, L; Martyr, A; Gamble, LD; et al.
    19 January 2021Increasing skeletal muscle carnitine content in older individuals increases whole-body fat oxidation during moderate-intensity exercise  Chee, C; Shannon, CE; Burns, A; et al.
    17 November 2020Mild Cognitive Impairment: the Manchester Consensus  Dunne, RA; Aarsland, D; O'Brien, JT; et al.
    9 March 2022Minimal Impact of COVID-19 Pandemic on the Mental Health and Wellbeing of People Living With Dementia: Analysis of Matched Longitudinal Data From the IDEAL Study  Sabatini, S; Bennett, HQ; Martyr, A; et al.
    18 November 2019Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: A randomized clinical trial  Howard, R; Zubko, O; Bradley, R; et al.
    31 October 2018MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR)  Kessler, DS; McNeill, SJ; Tallon, D; et al.
    31 October 2018MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR)  Kessler, DS; McNeill, SJ; Tallon, D; et al.
    31 October 2018Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).  Kessler, DS; MacNeill, SJ; Tallon, D; et al.
    1 April 2016Novel insight regarding the trajectory and time-course of immobilisation induced impairment of limb glucose uptake in healthy volunteers  Burns, A; Nixon, A; Stephens, F; et al.
    22 January 2013A pilot randomised controlled trial of cognitive behavioural therapy for antenatal depression  Burns, A; O'Mahen, H; Baxter, H; et al.
    1 April 2016Relative contribution of intramyocellular lipid to whole-body fat oxidation is reduced with age but subsarcolemmal lipid accumulation and insulin resistance are only associated with overweight individuals.  Chee, C; Shannon, CE; Burns, A; et al.
    20 January 2023Workload and workflow implications associated with the use of electronic clinical decision support tools used by health professionals in general practice: a scoping review  Fletcher, E; Burns, A; Wiering, B; et al.